1
The FDA found the use of MDMA to be a “'breakthrough' treatment in 2017, but approval could take several years
The party drug that goes by its chemical name MDMA (short for 3,4-Methylenedioxymethamphetamine) previously branded as ecstasy, may have therapeutic value, according to emerging studies that will include a research trial by Israel’s Health Ministry, Haaretz reported on Sunday.
MDMA will be administered to about 50 patients in the approved program who have been diagnosed with post-traumatic stress disorder in the course of psychiatric treatment.
Although the drug is classified as a “dangerous drug” in Israel, the health ministry approved a “compassionate use” trial that will see it administered to dozens of patients suffering from Post-Traumatic Stress Disorder (PTSD) due to a lack of effective treatment alternatives.
Hors ligne
[ Forum ] Cannabis médical - Cannabis médical : Des patients témoignent
|
9 | |
[ Forum ] Social - Des médecins qui affichent refuser les patients précaires
|
6 | |
[ Forum ] Santé - Infections nosocomiales : des milliers de patients contaminés ?
|
1 | |
[ PsychoWIKI ] Ecstasy-MDMA, effets, risques, témoignages | ||
[ PsychoWIKI ] Ecstasy-MDMA, la première fois | ||
[ QuizzZ ] Consommez-vous le MDMA/Ecstasy à moindre risque ?
10902 personnes ont déja passé ce quizzz ! |